|
Audience: This activity is intended for
healthcare professionals practicing in managed care environments.
This activity is supported by an
educational grant from AstraZenca
PLEASE CLICK HERE TO READ THE ARTICLE
PLEASE CLICK HERE FOR POST TEST AND
EVALUATION
Instructions for CME/CEU: Read the article, answer the
post test, complete the evaluation form and submit to
keads@namcp.org. You will
have the option on the post test/evaluation page to submit your
forms electronically or by faxing them to Katie Eads at
804-747-5316.
Summary
To best manage patients with hyperlipidemia, clinicians need to use
an evidence based approach. Based on the evidence, statins are the
medications of choice for most patients who need lipid lowering
therapy. The presence of various risk factors will determine the
appropriate LDL goal for a particular patient. Some patients can
benefit from aggressive lipid lowering.
Objectives
|
Faculty: |
John Varras, MD, University
of Nevada School of Medicine |
| |
|
|
Disclosure:
|
Dr. Varras has no financial
relationships to disclose |
Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is
accredited by the Accreditation Council for Continuing Medical
Education to sponsor continuing medical education for physicians.
NAMCP designates this activity for a maximum of 1 AMA PRA Category I
creditsTM. Each physician should claim credit commensurate with the
extent of their participation in the activity.
The American Association of Managed Care Nurses (AAMCN) has been
approved as a provider of continuing education by the Virginia
Nurses Association (VNA) VNA is accredited as an approver of
continuing education in nursing by the American Nurses Credentialing
Center’s Commission on Accreditation. Nurses who complete this
activity will be awarded 1.0 contact hours.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
requirements.
This activity is supported by an
educational grant from AstraZenca
|